Call for Proposals: Grants for R&D in Vaccine and Pharmaceutical Manufacturing in Ghana

Are you working to innovate Ghana’s pharmaceutical and vaccine manufacturing sector? Apply now for funding of as much as EUR 500,000 to help analysis and growth (R&D) initiatives that promote the invention, growth, and native manufacturing of vaccines, medicines, and well being applied sciences.

The National Vaccine Institute of Ghana and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, as part of the PharmaVax Ghana programme, are accepting proposals from collaborative analysis partnerships. The name is open till 1 June 2025.

This initiative is part of the broader Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+), and is co-financed by the European Union (EU) and the German Federal Ministry for Economic Cooperation and Development (BMZ).

---

About the Programme

PharmaVax Ghana is a strategic programme that goals to strengthen Ghana’s pharmaceutical and vaccine ecosystem by funding in R&D, infrastructure, and innovation. By fostering native manufacturing capabilities, the initiative contributes to bettering well being safety, lowering dependency on imports, and enhancing the provision of essential medicines and vaccines.

This name for proposals focuses on funding utilized analysis initiatives that may catalyze innovation and development in the native well being sector.

---

Areas of Focus

The programme will fund utilized R&D work throughout the next precedence areas:

• Vaccines (together with biosimilars) and different organic merchandise

• Sera, together with anti-venoms

• Herbal medicines

• Medicines for uncared for tropical illnesses and orphan medicine

• Pharmaceuticals for non-communicable illnesses and infectious illnesses

• Medical diagnostics and gadgets for drug application

• Veterinary vaccines

Eligible initiatives could span from early-stage drug discovery and growth, improvements in formulation, to scientific trials and associated utilized analysis.

---

Who Can Apply?

Applications are open to partnership consortia engaged in pharmaceutical or vaccine R&D. Each consortium should meet the next standards:

• Be led by a Ghanaian public or personal analysis establishment

• Include no less than one Ghanaian pharmaceutical producer as a co-applicant

• Additional collaborators, together with worldwide companions, are welcome

Collaborations that foster native capability, gender inclusion, and South-South data trade are strongly inspired.

---

Funding Scope

Three funding tiers can be found, relying on undertaking scale and scope. All initiatives have to be accomplished inside 24 months:

• Up to EUR 125,000

• Up to EUR 300,000

• Up to EUR 500,000

Funding is awarded on a aggressive foundation, with proposals evaluated towards a set of predefined standards outlined in the official steerage pack.

---

How to Apply

Interested consortia ought to obtain and evaluate the total info pack and application type, which incorporates detailed eligibility necessities, analysis standards, and submission directions.

Download the information pack here

Proposals have to be submitted by 1 June 2025. Incomplete or late purposes won’t be thought of.

---

Contact

For questions or extra particulars, please contact the programme group at:
CFP-PharmaVaxGH@giz.de

---

For extra info, go to the official website
For extra alternatives, go to the Opportunities for Youth web site

Related